Amersham International
This article was originally published in The Gray Sheet
Executive Summary
Japan approves for marketing the Myoview technetium-based injectable radiopharmaceutical kit for functional imaging of the heart. Myoview will be sold in Japan for evaluation of heart disease by myocardial scintigraphy and evaluation of myocardial function by first-pass technique, Amersham says